Nutra Pharma Corp. Engages Isserman Consulting For Public Awareness And Investor Relations

BOYNTON BEACH, Fla.--(BUSINESS WIRE)--Dec. 27, 2005--Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology holding company that owns rights to intellectual property related to the development of drugs for HIV and Multiple Sclerosis, has announced that it has retained Isserman Consulting to lead a comprehensive press communications and shareholder relations campaign. Based in Saint Louis, Isserman Consulting provides a variety of custom services for public companies seeking results-oriented investor relations programs.